Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

19

Revenue 2017

Celgene

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Celgene's 2013 oncology sales performance.

Celgene

Amgen reports positive results for inflammatory disease drug Otezla in psoriatic arthritis

Amgen reports positive results for inflammatory disease drug Otezla in psoriatic arthritis

Amgen bought Otezla from Celgene Corporation in 2019 for $13.4bn to strengthen its inflammation portfolio.

Testimonials

society alike – values which Celgene strive to achieve. ... Lisa McCurdy, Associate Director - Haematology, Celgene. “You never forget that feeling of being a winner and of knowing that you are at the very top of your profession – it means that

FDA approves Amgen’s Otezla for all patients with plaque psoriasis

FDA approves Amgen’s Otezla for all patients with plaque psoriasis Celgene’s top psoriasis drug, Otezla (apremilast), which was raking in $1.6bn a year and growing fast, clashed with one of BMS' most promising molecules, deucravacitinib. ... As it became clear that anti-competition regulators would balk at BMS owning

Merck to acquire Acceleron in a deal worth around $11.5bn

Merck to acquire Acceleron in a deal worth around $11.5bn The drug is part of a long-standing global collaboration with Celgene, now part of Bristol Myers Squibb (BMS).

Mysterious big pharma company eyes US biotech Acceleron

Mysterious big pharma company eyes US biotech Acceleron The drug is part of a long-standing global collaboration with Celgene, now part of Bristol Myers Squibb (BMS).

1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

Subscribe to our email news alerts

PMHub

Add my company
Genetic Digital

We guide healthcare and life sciences organisations through digital transformation. Simplifying the complex world of tech and marketing, we create...

Latest intelligence

New Playbook Alert: Virtual Patient Engagement
...
Millennials: the wellness generation
Looking at the results from a global healthcare research study focusing on the patients of the future...
The problem with clinical trials (and how virtual insight-gathering can help)
While still the gold standard of research, clinical trials are often riddled with issues that limit their applicability to broader populations or delay market access....